SCHEMBL6162658

SCHEMBL6162658

CC(C)N(C)Cc1cnnn1-c1cccc(C2=Nc3cc(N(C)C(C)C)c(C(F)(F)F)cc3NC(=O)C2)c1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167547 0.95 GRM2 (0.46) GRM2
SCHEMBL6163565 0.92 GRM2 (0.46) GRM2
SCHEMBL6164048 0.92 CYP3A4 (0.46) GRM2
SCHEMBL6165796 0.90 GRM2 (0.44) GRM2
SCHEMBL6167251 0.89 GRM2 (0.44) GRM2
SCHEMBL6164824 0.89 GRM2 (0.42) GRM2
SCHEMBL6167157 0.88 GRM2 (0.43) GRM2
SCHEMBL6165676 0.87 GRM2 (0.48) GRM2
SCHEMBL6165856 0.87 GRM2 (0.42) GRM2
SCHEMBL6164534 0.86 GRM2 (0.47) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379511-B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II HOFFMANN LA ROCHE (CH) 2005-07-20 EP disclosed
US-6544985-B2 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits HOFFMAN-LA ROCHE INC. 2003-04-08 US disclosed